Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

Pages

Shots - Health News
12:16 pm
Tue November 25, 2014

Treatment For HIV Runs Low In U.S., Despite Diagnosis

A pharmacist pours Truvada pills, an HIV treatment, back into the bottle at Jack's Pharmacy in San Anselmo, Calif.
Justin Sullivan Getty Images

Originally published on Wed November 26, 2014 11:35 am

About two-thirds of Americans who are infected with the virus that causes AIDS aren't getting treated for it.

The finding comes from an analysis just released by the Centers for Disease Control and Prevention showing that more needs to be done to make sure people infected with the human immunodeficiency virus get proper treatment.

Read more
Shots - Health News
2:03 am
Mon November 10, 2014

Combining The DNA Of Three People Raises Ethical Questions

Daniel Horowitz for NPR

Originally published on Mon November 10, 2014 4:03 pm

In a darkened lab in the north of England, a research associate is intensely focused on the microscope in front of her. She carefully maneuvers a long glass tube that she uses to manipulate early human embryos.

"It's like microsurgery," says Laura Irving of Newcastle University.

Irving is part of a team of scientists trying to replace defective DNA with healthy DNA. They hope this procedure could one day help women who are carrying genetic disorders have healthy children.

Read more
Research News
5:37 am
Wed October 15, 2014

Study Finds Human Stem Cells May Help To Treat Patients

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

AUDIE CORNISH, HOST:

For the first time ever, scientists are reporting that human embryonic stem cells may be helping treat patients. In the medical journal The Lancet, researchers describe how the cells seem to help restore eyesight to some blind people.

Read more
Shots - Health News
5:33 pm
Tue October 14, 2014

Embryonic Stem Cells Restore Vision In Preliminary Human Test

Isabella Beukes, of Santa Rosa, Calif., has been legally blind for more than 40 years. An experimental treatment derived from embryonic stem cells seems to have enabled her now to see not just color but also some shapes.
Tim Hussin for NPR

Originally published on Fri October 17, 2014 10:39 am

Scientists are reporting the first strong evidence that human embryonic stem cells may be helping patients.

The cells appear to have improved the vision in more than half of the 18 patients who had become legally blind because of two progressive, currently incurable eye diseases.

The researchers stress that the findings must be considered preliminary because the number of patients treated was relatively small and they have only been followed for an average of less than two years.

Read more
Shots - Health News
11:18 am
Thu October 9, 2014

Scientists Coax Human Embryonic Stem Cells Into Making Insulin

Insulin is produced by the green cells that are in clusters about the same size as the islets in the human pancreas. The red cells are producing another metabolic hormone, glucagon, that prevents low blood sugar.
Harvard University

Originally published on Thu October 9, 2014 5:28 pm

A team of Harvard scientists said Thursday that they had finally found a way to turn human embryonic stem cells into cells that produce insulin. The long-sought advance could eventually lead to new ways to help millions of people with diabetes.

Right now, many people with diabetes have to regularly check the level of sugar in their blood and inject themselves with insulin to keep the sugar in their blood in check. It's an imperfect treatment.

Read more
Research News
3:58 am
Mon October 6, 2014

'Inner GPS' Discovery Wins Nobel Prize In Medicine

Originally published on Mon October 6, 2014 11:32 am

Copyright 2014 NPR. To see more, visit http://www.npr.org/.

Transcript

RACHEL MARTIN, HOST:

Read more
Shots - Health News
3:24 pm
Mon September 8, 2014

Researcher Urges Wider Genetic Screening For Breast Cancer

Lisa Schlager of Chevy Chase, Md., demonstrates outside of the Supreme Court as arguments were made in a case seeking to determine whether the BRCA breast cancer genes can be patented. The court ruled in 2013 that individual genes can't be patented.
Tom Williams CQ Roll Call/Getty

Originally published on Tue September 9, 2014 11:43 am

A prominent scientist has started a big new debate about breast cancer. Geneticist Mary-Claire King of the University of Washington, who identified the first breast cancer gene, is recommending that all women get tested for genetic mutations that can cause breast cancer.

Read more
Shots - Health News
12:38 pm
Fri August 29, 2014

Experimental Drug Saves Monkeys Stricken With Ebola

A Public Health Agency of Canada worker seen inside the National Microbiology Laboratory's Level 4 lab in Winnipeg.
Public Health Agency of Canada/Nature

Originally published on Fri August 29, 2014 7:40 pm

Scientists are reporting strong evidence that the experimental Ebola drug ZMapp may be effective for treating victims of the devastating disease.

A study involving 18 rhesus macaque monkeys, published Friday in the journal Nature, found that the drug saved 100 percent of the animals even if they didn't receive the drug until five days after they had been infected. The study is the first to test ZMapp in a primate, which is considered a good model for how a drug might work in humans.

Read more
Goats and Soda
2:31 am
Fri August 22, 2014

The Dread Factor: Why Ebola And 'Contagion' Scare Us So Much

Jude Law prepares for the looming pandemic in the 2011 movie Contagion. There are huge differences between viruses in movies and Ebola in real life.
Warner Bros/The Kobal Collection

Originally published on Fri August 22, 2014 9:16 am

The Ebola outbreak has set off an alarm around the world. Public health leaders say the intense concern is appropriate, given the unprecedented size of the outbreak and the deadliness of the virus.

But experts say the outbreak has also produced a lot of unfounded fears. Even just the word Ebola is kind of terrifying.

Why? Well, Hollywood has a lot to do with it.

Read more
Shots - Health News
2:35 am
Thu August 14, 2014

Who Gets First Dibs On Transplanted Liver? Rules May Change

Surgeons at Methodist University Hospital in Memphis prepare to transplant a liver in 2010.
Karen Pulfer Focht The Commercial Appeal/Landov

Originally published on Thu August 14, 2014 8:21 am

Vicki Hornbuckle used to play the piano at her church. But that was before her liver started failing.

"I had to give it up because I couldn't keep up," says Hornbuckle, 54, of Snellville, Georgia. "I didn't have the energy to do three services on Sunday. You're just too tired to deal with anything. And so, it's not a life that you want to live."

But Hornbuckle hasn't given up. She's fighting to stay alive long enough to get a liver transplant.

Read more

Pages